Number of Pharmacy Bankruptcies Hits Record High of 30; “Monzen” Pharmacies Near Hospitals Stand Out; Rise of Drugstores with Dispensing Functions Cited as Factor – FNN Prime Online

News Summary

In April 2026, the number of pharmacy bankruptcies reached a record high of 30. Bankruptcies were particularly noticeable among “monzen” pharmacies located near hospitals, with the increase in drugstores equipped with dispensing functions seen as a primary factor. This situation highlights the urgency of business succession in the dispensing pharmacy industry.

Perspective from M&A Medical Editorial Department

The figure of 30 bankruptcies, a record high for dispensing pharmacies, reflects the rapid structural changes in the industry. The fact that monzen pharmacies, especially those near hospitals, are being hit hard suggests the vulnerability of a prescription-dependent business model. The offensive by drugstores that have strengthened their dispensing functions is not merely competition; it has the potential to prompt a reorganization of the regional healthcare provision system itself. For example, moves by major drugstore chains to acquire existing monzen pharmacies and integrate their dispensing functions to meet broader regional needs and pursue economies of scale are expected to accelerate further. This trend forces individual dispensing pharmacy owners to calmly analyze their own strengths and weaknesses and consider options such as business restructuring through M&A or collaboration with other industries at an early stage.

Key Discussion Points from This News

• Vulnerability of Monzen Pharmacies: The limitations of a prescription-dependent business model are exposed, creating a structure susceptible to the impact of declining unit prices and prescription volumes.
• Evolution of Drugstores: Transformation from mere sales channels to regional healthcare service providers centered on dispensing functions.
• Reorganization of Regional Healthcare Provision Systems: Potential acceleration of consolidation and restructuring of small and medium-sized pharmacies, driven by M&A and integration by major chains.
• Diversification of Business Succession: The need to consider not only M&A but also collaboration with other industries and transitions to new service models.

Practical Questions Arising from This News

• Is my pharmacy also likely to be acquired by a drugstore?
• Is it possible to transition from a monzen pharmacy to a drugstore with dispensing functions?
• What specific M&A schemes can be considered to avoid the risk of bankruptcy?

If You Feel “Should I Consult Too?”

The news of a record high in dispensing pharmacy bankruptcies is not something to be taken lightly. If your pharmacy is experiencing a downward trend in prescription volume or medical profit margins, or if you are concerned about the future due to a lack of a successor, now is the perfect time to consult with experts. By considering M&A or business restructuring options early on, the possibility of succession under more favorable terms or continuing your business increases. Let’s start by objectively assessing your current business situation.

M&A Medical (CentralMedience Inc.) supports business succession for medical corporations, hospitals, and clinics with a complete success-fee basis, as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultations are available here.